Click here to get full coverage on Precigen (PGEN) awards CCO 115,000 RSUs and 385,000 options - Stock Titan

Precigen (PGEN) awards CCO 115,000 RSUs and 385,000 options  Stock Titan

Precigen (PGEN) awards CCO 115,000 RSUs and 385,000 options - Stock Titan

Click here to get full coverage on Precigen (PGEN) Stock: Technical Risk Signals | Q4 2025: EPS Tops Views - Social Trade Signals - UBND thành phố Hải Phòng

Precigen (PGEN) Stock: Technical Risk Signals | Q4 2025: EPS Tops Views - Social Trade Signals  UBND thành phố Hải Phòng

Precigen (PGEN) Stock: Technical Risk Signals | Q4 2025: EPS Tops Views - Social Trade Signals - UBND thành phố Hải Phòng

Click here to get full coverage on Precigen Reports Full Year 2025 Financial Results and Business Updates - PR Newswire

Precigen Reports Full Year 2025 Financial Results and Business Updates  PR Newswire

Precigen Reports Full Year 2025 Financial Results and Business Updates - PR Newswire

Click here to get full coverage on PGEN Stock Price, Quote & Chart | PRECIGEN INC (NASDAQ:PGEN) - ChartMill

PGEN Stock Price, Quote & Chart | PRECIGEN INC (NASDAQ:PGEN)  ChartMill

PGEN Stock Price, Quote & Chart | PRECIGEN INC (NASDAQ:PGEN) - ChartMill

Click here to get full coverage on PGEN (Precigen Inc.) reports narrower Q4 2025 loss than estimates, shares rise slightly on positive investor sentiment. - Consensus Forecast - Cổng thông tin điện tử Tỉnh Sơn La

PGEN (Precigen Inc.) reports narrower Q4 2025 loss than estimates, shares rise slightly on positive investor sentiment. - Consensus Forecast  Cổng thông tin điện tử Tỉnh Sơn La

PGEN (Precigen Inc.) reports narrower Q4 2025 loss than estimates, shares rise slightly on positive investor sentiment. - Consensus Forecast - Cổng thông tin điện tử Tỉnh Sơn La

Click here to get full coverage on Precigen (PGEN) Surged Following the Early Approval of Papziemos - Yahoo Finance

Precigen (PGEN) Surged Following the Early Approval of Papziemos  Yahoo Finance

Precigen (PGEN) Surged Following the Early Approval of Papziemos - Yahoo Finance

Click here to get full coverage on Precigen (PGEN) awards RSUs and stock options to Chief Legal Officer - Stock Titan

Precigen (PGEN) awards RSUs and stock options to Chief Legal Officer  Stock Titan

Precigen (PGEN) awards RSUs and stock options to Chief Legal Officer - Stock Titan

Click here to get full coverage on Is Precigen’s (PGEN) New PAPZIMEOS J-Code Reframing Its Respiratory Growth Narrative? - simplywall.st

Is Precigen’s (PGEN) New PAPZIMEOS J-Code Reframing Its Respiratory Growth Narrative?  simplywall.st

Is Precigen’s (PGEN) New PAPZIMEOS J-Code Reframing Its Respiratory Growth Narrative? - simplywall.st

Click here to get full coverage on PGEN (Precigen) beats Q4 2025 EPS expectations, posts 146.7 percent revenue growth as shares rise 3.27 percent. - Forward Guidance - Xã Thanh Hà

PGEN (Precigen) beats Q4 2025 EPS expectations, posts 146.7 percent revenue growth as shares rise 3.27 percent. - Forward Guidance  Xã Thanh Hà

PGEN (Precigen) beats Q4 2025 EPS expectations, posts 146.7 percent revenue growth as shares rise 3.27 percent. - Forward Guidance - Xã Thanh Hà

Click here to get full coverage on Precigen Showcases Rapid Commercialization Momentum and Growing Market Adoption of First-and-Only FDA-Approved Therapy for RRP at the 44th Annual J.P. Morgan Healthcare Conference - PR Newswire

Precigen Showcases Rapid Commercialization Momentum and Growing Market Adoption of First-and-Only FDA-Approved Therapy for RRP at the 44th Annual J.P. Morgan Healthcare Conference  PR Newswire

Precigen Showcases Rapid Commercialization Momentum and Growing Market Adoption of First-and-Only FDA-Approved Therapy for RRP at the 44th Annual J.P. Morgan Healthcare Conference - PR Newswire

Click here to get full coverage on Assessing Precigen (PGEN) Valuation After Recent Share Price Weakness And Conflicting Fair Value Estimates - Yahoo Finance

Assessing Precigen (PGEN) Valuation After Recent Share Price Weakness And Conflicting Fair Value Estimates  Yahoo Finance

Assessing Precigen (PGEN) Valuation After Recent Share Price Weakness And Conflicting Fair Value Estimates - Yahoo Finance

Click here to get full coverage on Precigen (PGEN) COO Rutul Shah receives new RSU and stock option grants - Stock Titan

Precigen (PGEN) COO Rutul Shah receives new RSU and stock option grants  Stock Titan

Precigen (PGEN) COO Rutul Shah receives new RSU and stock option grants - Stock Titan

Click here to get full coverage on Precigen Reports Third Quarter 2025 Financial Results and Business Updates - PR Newswire

Precigen Reports Third Quarter 2025 Financial Results and Business Updates  PR Newswire

Precigen Reports Third Quarter 2025 Financial Results and Business Updates - PR Newswire

Click here to get full coverage on Is It Too Late To Consider Precigen (PGEN) After Its 145% One Year Surge? - Yahoo Finance

Is It Too Late To Consider Precigen (PGEN) After Its 145% One Year Surge?  Yahoo Finance

Is It Too Late To Consider Precigen (PGEN) After Its 145% One Year Surge? - Yahoo Finance

Click here to get full coverage on Precigen (PGEN) CFO receives 120,000 RSUs and options on 399,000 shares - Stock Titan

Precigen (PGEN) CFO receives 120,000 RSUs and options on 399,000 shares  Stock Titan

Precigen (PGEN) CFO receives 120,000 RSUs and options on 399,000 shares - Stock Titan

Click here to get full coverage on Precigen Announces Up to $125 Million Non-Dilutive Financing - PR Newswire

Precigen Announces Up to $125 Million Non-Dilutive Financing  PR Newswire

Precigen Announces Up to $125 Million Non-Dilutive Financing - PR Newswire

Click here to get full coverage on Precigen (PGEN) CEO receives large RSU and stock option grants - Stock Titan

Precigen (PGEN) CEO receives large RSU and stock option grants  Stock Titan

Precigen (PGEN) CEO receives large RSU and stock option grants - Stock Titan

Click here to get full coverage on Precigen, Inc. (PGEN) Poised for Growth on Respiratory Papillomatosis Treatment Prospects - Yahoo Finance

Precigen, Inc. (PGEN) Poised for Growth on Respiratory Papillomatosis Treatment Prospects  Yahoo Finance

Precigen, Inc. (PGEN) Poised for Growth on Respiratory Papillomatosis Treatment Prospects - Yahoo Finance

Click here to get full coverage on Is Precigen Inc. (PGEN) The Best Healthcare Penny Stock to Buy? - Yahoo Finance

Is Precigen Inc. (PGEN) The Best Healthcare Penny Stock to Buy?  Yahoo Finance

Is Precigen Inc. (PGEN) The Best Healthcare Penny Stock to Buy? - Yahoo Finance

Click here to get full coverage on New Expert Consensus Published in The Laryngoscope Recommends PAPZIMEOS (zopapogene imadenovec) as the New Standard of Care First-Line Treatment for Adults with Recurrent Respiratory Papillomatosis - PR Newswire

New Expert Consensus Published in The Laryngoscope Recommends PAPZIMEOS (zopapogene imadenovec) as the New Standard of Care First-Line Treatment for Adults with Recurrent Respiratory Papillomatosis  PR Newswire

New Expert Consensus Published in The Laryngoscope Recommends PAPZIMEOS (zopapogene imadenovec) as the New Standard of Care First-Line Treatment for Adults with Recurrent Respiratory Papillomatosis - PR Newswire

Click here to get full coverage on Wall Street Bullish on ​Precigen (PGEN) As the Company Transitions to Commercial Stage - Yahoo Finance

Wall Street Bullish on ​Precigen (PGEN) As the Company Transitions to Commercial Stage  Yahoo Finance

Wall Street Bullish on ​Precigen (PGEN) As the Company Transitions to Commercial Stage - Yahoo Finance

Click here to get full coverage on $PGEN ($PGEN) Releases Q4 2025 Earnings, Stock Rises - Quiver Quantitative

$PGEN ($PGEN) Releases Q4 2025 Earnings, Stock Rises  Quiver Quantitative

$PGEN ($PGEN) Releases Q4 2025 Earnings, Stock Rises - Quiver Quantitative

Click here to get full coverage on Rare disease drug aimed at reducing surgeries lifts Precigen Q1 view above $18M - Stock Titan

Rare disease drug aimed at reducing surgeries lifts Precigen Q1 view above $18M  Stock Titan

Rare disease drug aimed at reducing surgeries lifts Precigen Q1 view above $18M - Stock Titan

Click here to get full coverage on Precigen Inc (PGEN) Q3 2025 Earnings Call Highlights: FDA Approval and U.S. ... - Yahoo Finance

Precigen Inc (PGEN) Q3 2025 Earnings Call Highlights: FDA Approval and U.S. ...  Yahoo Finance

Precigen Inc (PGEN) Q3 2025 Earnings Call Highlights: FDA Approval and U.S. ... - Yahoo Finance

Click here to get full coverage on A Look At Precigen (PGEN) Valuation As PAPZIMEOS Commercial Launch And J Code Spark Investor Interest - simplywall.st

A Look At Precigen (PGEN) Valuation As PAPZIMEOS Commercial Launch And J Code Spark Investor Interest  simplywall.st

A Look At Precigen (PGEN) Valuation As PAPZIMEOS Commercial Launch And J Code Spark Investor Interest - simplywall.st

Click here to get full coverage on Precigen, Inc. (PGEN) Builds Commercial Stage With Global Regulatory Support - Yahoo Finance

Precigen, Inc. (PGEN) Builds Commercial Stage With Global Regulatory Support  Yahoo Finance

Precigen, Inc. (PGEN) Builds Commercial Stage With Global Regulatory Support - Yahoo Finance

Click here to get full coverage on Precigen, Inc. (PGEN) Reports Q4 Loss, Lags Revenue Estimates - Yahoo Finance

Precigen, Inc. (PGEN) Reports Q4 Loss, Lags Revenue Estimates  Yahoo Finance

Precigen, Inc. (PGEN) Reports Q4 Loss, Lags Revenue Estimates - Yahoo Finance

Click here to get full coverage on A Look at Precigen (PGEN) Valuation Following FDA Approval of PAPZIMEOS for Recurrent Respiratory Papillomatosis - Yahoo Finance

A Look at Precigen (PGEN) Valuation Following FDA Approval of PAPZIMEOS for Recurrent Respiratory Papillomatosis  Yahoo Finance

A Look at Precigen (PGEN) Valuation Following FDA Approval of PAPZIMEOS for Recurrent Respiratory Papillomatosis - Yahoo Finance

Click here to get full coverage on PGEN Stock Surges 144% in August on FDA Nod for Rare Lung Disease Drug - Yahoo Finance

PGEN Stock Surges 144% in August on FDA Nod for Rare Lung Disease Drug  Yahoo Finance

PGEN Stock Surges 144% in August on FDA Nod for Rare Lung Disease Drug - Yahoo Finance

Click here to get full coverage on Precigen, Inc. (NASDAQ:PGEN): Is Breakeven Near? - Yahoo Finance

Precigen, Inc. (NASDAQ:PGEN): Is Breakeven Near?  Yahoo Finance

Precigen, Inc. (NASDAQ:PGEN): Is Breakeven Near? - Yahoo Finance

Click here to get full coverage on Precigen stock gains on Q1 2026 outlook (PGEN:NASDAQ) - Seeking Alpha

Precigen stock gains on Q1 2026 outlook (PGEN:NASDAQ)  Seeking Alpha

Precigen stock gains on Q1 2026 outlook (PGEN:NASDAQ) - Seeking Alpha

Click here to get full coverage on Cantor Fitzgerald Reaffirms Overweight Rating on Precigen (PGEN) - Yahoo Finance

Cantor Fitzgerald Reaffirms Overweight Rating on Precigen (PGEN)  Yahoo Finance

Cantor Fitzgerald Reaffirms Overweight Rating on Precigen (PGEN) - Yahoo Finance

Click here to get full coverage on Precigen CEO and commercial chief join March 31 investor chat - Stock Titan

Precigen CEO and commercial chief join March 31 investor chat  Stock Titan

Precigen CEO and commercial chief join March 31 investor chat - Stock Titan

Click here to get full coverage on Is Precigen (PGEN) Reflecting Its Recent Surge Despite Steep Short Term Pullback - simplywall.st

Is Precigen (PGEN) Reflecting Its Recent Surge Despite Steep Short Term Pullback  simplywall.st

Is Precigen (PGEN) Reflecting Its Recent Surge Despite Steep Short Term Pullback - simplywall.st

Click here to get full coverage on Precigen, Inc. (NASDAQ:PGEN): Are Analysts Optimistic? - simplywall.st

Precigen, Inc. (NASDAQ:PGEN): Are Analysts Optimistic?  simplywall.st

Precigen, Inc. (NASDAQ:PGEN): Are Analysts Optimistic? - simplywall.st

Click here to get full coverage on H.C. Wainwright Remains Bullish on Precigen (PGEN) - Yahoo Finance

H.C. Wainwright Remains Bullish on Precigen (PGEN)  Yahoo Finance

H.C. Wainwright Remains Bullish on Precigen (PGEN) - Yahoo Finance

Click here to get full coverage on Randal J. Kirk (PGEN) entities sell 4.8M shares, still hold over one-third stake - Stock Titan

Randal J. Kirk (PGEN) entities sell 4.8M shares, still hold over one-third stake  Stock Titan

Randal J. Kirk (PGEN) entities sell 4.8M shares, still hold over one-third stake - Stock Titan

Click here to get full coverage on Precigen, Inc. (PGEN) Stock Analysis: Unveiling A 123% Upside Potential In Biotech - DirectorsTalk Interviews

Precigen, Inc. (PGEN) Stock Analysis: Unveiling A 123% Upside Potential In Biotech  DirectorsTalk Interviews

Precigen, Inc. (PGEN) Stock Analysis: Unveiling A 123% Upside Potential In Biotech - DirectorsTalk Interviews

Click here to get full coverage on PGEN SEC Filings - Precigen Inc 10-K, 10-Q, 8-K Forms - Stock Titan

PGEN SEC Filings - Precigen Inc 10-K, 10-Q, 8-K Forms  Stock Titan

PGEN SEC Filings - Precigen Inc 10-K, 10-Q, 8-K Forms - Stock Titan

Click here to get full coverage on Precigen Announces Full FDA Approval of PAPZIMEOS (zopapogene imadenovec-drba), the First and Only Approved Therapy for the Treatment of Adults with Recurrent Respiratory Papillomatosis - PR Newswire

Precigen Announces Full FDA Approval of PAPZIMEOS (zopapogene imadenovec-drba), the First and Only Approved Therapy for the Treatment of Adults with Recurrent Respiratory Papillomatosis  PR Newswire

Precigen Announces Full FDA Approval of PAPZIMEOS (zopapogene imadenovec-drba), the First and Only Approved Therapy for the Treatment of Adults with Recurrent Respiratory Papillomatosis - PR Newswire

Click here to get full coverage on Precigen (PGEN) Quarterly Loss Swings Challenge Bullish Growth Narrative After FY 2025 Results - simplywall.st

Precigen (PGEN) Quarterly Loss Swings Challenge Bullish Growth Narrative After FY 2025 Results  simplywall.st

Precigen (PGEN) Quarterly Loss Swings Challenge Bullish Growth Narrative After FY 2025 Results - simplywall.st

Click here to get full coverage on Precigen’s (PGEN) Papzimeos Push Sparks Multibagger Ascent, Boosted by Analyst Optimism - Yahoo Finance

Precigen’s (PGEN) Papzimeos Push Sparks Multibagger Ascent, Boosted by Analyst Optimism  Yahoo Finance

Precigen’s (PGEN) Papzimeos Push Sparks Multibagger Ascent, Boosted by Analyst Optimism - Yahoo Finance

Click here to get full coverage on Precigen director exercises 143,678 RSUs into shares | PGEN Insider Trading - Stock Titan

Precigen director exercises 143,678 RSUs into shares | PGEN Insider Trading  Stock Titan

Precigen director exercises 143,678 RSUs into shares | PGEN Insider Trading - Stock Titan

Click here to get full coverage on 4,772,781 Precigen (PGEN) shares sold by entities tied to Randal Kirk - Stock Titan

4,772,781 Precigen (PGEN) shares sold by entities tied to Randal Kirk  Stock Titan

4,772,781 Precigen (PGEN) shares sold by entities tied to Randal Kirk - Stock Titan

Click here to get full coverage on New RRP treatment spreads nationwide as more insurers agree to cover it - Stock Titan

New RRP treatment spreads nationwide as more insurers agree to cover it  Stock Titan

New RRP treatment spreads nationwide as more insurers agree to cover it - Stock Titan

Click here to get full coverage on PGEN (NASDAQ: PGEN) files Form 144; lists past issuances and transfers - Stock Titan

PGEN (NASDAQ: PGEN) files Form 144; lists past issuances and transfers  Stock Titan

PGEN (NASDAQ: PGEN) files Form 144; lists past issuances and transfers - Stock Titan

Click here to get full coverage on Precigen (PGEN) Secures FDA Approval for Papillomatosis Treatment - Yahoo Finance

Precigen (PGEN) Secures FDA Approval for Papillomatosis Treatment  Yahoo Finance

Precigen (PGEN) Secures FDA Approval for Papillomatosis Treatment - Yahoo Finance

Click here to get full coverage on Precigen Is Still A Buy After The Papzimeos Rally (NASDAQ:PGEN) - Seeking Alpha

Precigen Is Still A Buy After The Papzimeos Rally (NASDAQ:PGEN)  Seeking Alpha

Precigen Is Still A Buy After The Papzimeos Rally (NASDAQ:PGEN) - Seeking Alpha

Click here to get full coverage on Wall Street bullish on Precigen (PGEN) as the company transitions to commercial stage - MSN

Wall Street bullish on Precigen (PGEN) as the company transitions to commercial stage  MSN

Wall Street bullish on Precigen (PGEN) as the company transitions to commercial stage - MSN

Click here to get full coverage on Precigen, Inc. Stock (PGEN) Opinions on FDA Approval of Papzimeos | PGEN Stock News - Quiver Quantitative

Precigen, Inc. Stock (PGEN) Opinions on FDA Approval of Papzimeos | PGEN Stock News  Quiver Quantitative

Precigen, Inc. Stock (PGEN) Opinions on FDA Approval of Papzimeos | PGEN Stock News - Quiver Quantitative

Click here to get full coverage on Precigen Reports First Quarter 2025 Financial Results and Business Updates - PR Newswire

Precigen Reports First Quarter 2025 Financial Results and Business Updates  PR Newswire

Precigen Reports First Quarter 2025 Financial Results and Business Updates - PR Newswire

Click here to get full coverage on How does news flow impact Precigen (PGEN) Stock | Price at $4.20, Down 1.76% - Real Time Stock Idea Network - Cổng thông tin điện tử tỉnh Lào Cai

How does news flow impact Precigen (PGEN) Stock | Price at $4.20, Down 1.76% - Real Time Stock Idea Network  Cổng thông tin điện tử tỉnh Lào Cai

How does news flow impact Precigen (PGEN) Stock | Price at $4.20, Down 1.76% - Real Time Stock Idea Network - Cổng thông tin điện tử tỉnh Lào Cai

Click here to get full coverage on Precigen: PAPZIMEOS Is Delivering For This Under-The-Radar Biotech (NASDAQ:PGEN) - Seeking Alpha

Precigen: PAPZIMEOS Is Delivering For This Under-The-Radar Biotech (NASDAQ:PGEN)  Seeking Alpha

Precigen: PAPZIMEOS Is Delivering For This Under-The-Radar Biotech (NASDAQ:PGEN) - Seeking Alpha

Click here to get full coverage on PRECIGEN (PGEN) CFO receives 40,293 RSUs and converts them into common stock - Stock Titan

PRECIGEN (PGEN) CFO receives 40,293 RSUs and converts them into common stock  Stock Titan

PRECIGEN (PGEN) CFO receives 40,293 RSUs and converts them into common stock - Stock Titan

Click here to get full coverage on Precigen (PGEN) director exercises RSUs, adds 71,839 common shares - Stock Titan

Precigen (PGEN) director exercises RSUs, adds 71,839 common shares  Stock Titan

Precigen (PGEN) director exercises RSUs, adds 71,839 common shares - Stock Titan

Click here to get full coverage on LOOK: Philippine National Police Chief, PGen Jose Melencio C. Nartatez, Jr., presided over the Philippine National Police Academy (PNPA) Turnover of Command Ceremony held this morning at the PNPA Heroes Hall, Camp General Mariano N. Castañeda, - facebook.com

LOOK: Philippine National Police Chief, PGen Jose Melencio C. Nartatez, Jr., presided over the Philippine National Police Academy (PNPA) Turnover of Command Ceremony held this morning at the PNPA Heroes Hall, Camp General Mariano N. Castañeda,  facebook.com

LOOK: Philippine National Police Chief, PGen Jose Melencio C. Nartatez, Jr., presided over the Philippine National Police Academy (PNPA) Turnover of Command Ceremony held this morning at the PNPA Heroes Hall, Camp General Mariano N. Castañeda, - facebook.com

Click here to get full coverage on Patient Capital Bets Big on Precigen (PGEN) By Acquiring 10.2 Million Shares - The Motley Fool

Patient Capital Bets Big on Precigen (PGEN) By Acquiring 10.2 Million Shares  The Motley Fool

Patient Capital Bets Big on Precigen (PGEN) By Acquiring 10.2 Million Shares - The Motley Fool

Click here to get full coverage on Precigen (PGEN): HC Wainwright & Co. Adjusts Price Target to $9. - GuruFocus

Precigen (PGEN): HC Wainwright & Co. Adjusts Price Target to $9.  GuruFocus

Precigen (PGEN): HC Wainwright & Co. Adjusts Price Target to $9. - GuruFocus

Click here to get full coverage on Precigen, Inc. (PGEN) Secures $125M to Accelerate PAPZIMEOS Commercialization - Yahoo Finance

Precigen, Inc. (PGEN) Secures $125M to Accelerate PAPZIMEOS Commercialization  Yahoo Finance

Precigen, Inc. (PGEN) Secures $125M to Accelerate PAPZIMEOS Commercialization - Yahoo Finance

Click here to get full coverage on Precigen (PGEN) Shares Surge on Positive Q1 Outlook Despite Earnings Miss - GuruFocus

Precigen (PGEN) Shares Surge on Positive Q1 Outlook Despite Earnings Miss  GuruFocus

Precigen (PGEN) Shares Surge on Positive Q1 Outlook Despite Earnings Miss - GuruFocus

Click here to get full coverage on Precigen, Inc. (PGEN) Stock Analysis: Unpacking The 100% Upside Potential - DirectorsTalk Interviews

Precigen, Inc. (PGEN) Stock Analysis: Unpacking The 100% Upside Potential  DirectorsTalk Interviews

Precigen, Inc. (PGEN) Stock Analysis: Unpacking The 100% Upside Potential - DirectorsTalk Interviews

Click here to get full coverage on Director at Precigen (NASDAQ: PGEN) receives stock, RSUs and options - Stock Titan

Director at Precigen (NASDAQ: PGEN) receives stock, RSUs and options  Stock Titan

Director at Precigen (NASDAQ: PGEN) receives stock, RSUs and options - Stock Titan

Click here to get full coverage on The Outlook For Precigen (NASDAQ:PGEN) - Seeking Alpha

The Outlook For Precigen (NASDAQ:PGEN)  Seeking Alpha

The Outlook For Precigen (NASDAQ:PGEN) - Seeking Alpha

Click here to get full coverage on Precigen (PGEN) posts 2025 loss as PAPZIMEOS launch drives revenue and costs - Stock Titan

Precigen (PGEN) posts 2025 loss as PAPZIMEOS launch drives revenue and costs  Stock Titan

Precigen (PGEN) posts 2025 loss as PAPZIMEOS launch drives revenue and costs - Stock Titan

Click here to get full coverage on Precigen: This Billion-Dollar Approval Is Still Undervalued (NASDAQ:PGEN) - Seeking Alpha

Precigen: This Billion-Dollar Approval Is Still Undervalued (NASDAQ:PGEN)  Seeking Alpha

Precigen: This Billion-Dollar Approval Is Still Undervalued (NASDAQ:PGEN) - Seeking Alpha

Click here to get full coverage on Is Precigen (PGEN) Stock Good for Short Term | Price at $4.16, Up 5.58% - Real-time Trade Ideas - Xã Thanh Hà

Is Precigen (PGEN) Stock Good for Short Term | Price at $4.16, Up 5.58% - Real-time Trade Ideas  Xã Thanh Hà

Is Precigen (PGEN) Stock Good for Short Term | Price at $4.16, Up 5.58% - Real-time Trade Ideas - Xã Thanh Hà

Click here to get full coverage on Precigen to Participate in Upcoming Virtual Fireside Chats Hosted by Cantor and H.C. Wainwright - PR Newswire

Precigen to Participate in Upcoming Virtual Fireside Chats Hosted by Cantor and H.C. Wainwright  PR Newswire

PGEN

Price Chart

Key Statistics

Technicals

About PGEN

Latest News

Precigen (PGEN) awards CCO 115,000 RSUs and 385,000 options - Stock Titan

Precigen (PGEN) Stock: Technical Risk Signals | Q4 2025: EPS Tops Views - Social Trade Signals - UBND thành phố Hải Phòng

Precigen Reports Full Year 2025 Financial Results and Business Updates - PR Newswire

Advanced Charts

Top Gainers

Top Losers